ArticleMarine drugs2023
Acute Effects of Brevetoxin-3 Administered via Oral Gavage to Mice.
Peggy Barbe, Jordi Molgó, Robert Thai, Apolline Urman, Denis Servent, Nathalie Arnich, Mathilde Keck
Open access · goldAbstract read
In one paragraphArticle in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors at 2 institutions in 1 country.
Peggy BarbeUniversité Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
Jordi MolgóUniversité Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-0693-8994 Robert ThaiUniversité Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
Apolline UrmanUniversité Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
Denis ServentUniversité Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-0774-1691 Nathalie ArnichRisk Assessment Directorate, ANSES-French Agency for Food, Environmental and Occupational Health and Safety, 94701 Maisons-Alfort, France.
Mathilde KeckUniversité Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.ORCID 0000-0003-4717-3446 Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FR
Funding
Atomic Energy and Alternative Energies Commission research & development agreementFrench Agency for Food, Environmental and Occupational Health & Safety a research & development agreement
6 · The paper itselfAbstract
Brevetoxins (BTXs) constitute a family of lipid-soluble toxic cyclic polyethers mainly produced by
Indexed as
Marine ToxinsOxocinsAnimalsFemaleHumansMaleMicePolyether Toxinsbrevetoxinbrevetoxin 3Marine ToxinsOxocinsPolyether ToxinsARfDbody temperaturebrevetoxin-3femalesmalesmiceoral gavagesymptomatology
Identifiers
PMID38132965
PMCPMC10744354
OpenAlexW4389917182
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390